Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Sunday, May 26, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drug

A woman filed a federal class action against Amag Inc., claiming its high-priced drug Makena (hydroxyprogesterone caproate) did not prevent pre-term birth, as advertised, causing her baby to die shortly after birth.

JOPLIN, Mo. — A woman filed a federal class action against Amag Inc., claiming its high-priced drug Makena (hydroxyprogesterone caproate) did not prevent pre-term birth, as advertised, causing her baby to die shortly after birth.

Categories / Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...